SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-14-131488
Filing Date
2014-04-04
Accepted
2014-04-04 14:51:06
Documents
2
Group Members
JON M. PLEXICOSTONEPINE CAPITAL MANAGEMENT, LLCTIMOTHY P. LYNCH

Document Format Files

Seq Description Document Type Size
1 SC 13G d706460dsc13g.htm SC 13G 79304
2 EX-99.1 d706460dex991.htm EX-99.1 5004
  Complete submission text file 0001193125-14-131488.txt   85917
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Subject) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43408 | Film No.: 14745556
SIC: 2834 Pharmaceutical Preparations

Mailing Address 475 GATE FIVE RD., SUITE 320 SAUSALITO CA 94965
Business Address 475 GATE FIVE RD., SUITE 320 SAUSALITO CA 94965 415.331.7100
STONEPINE CAPITAL L P (Filed by) CIK: 0001370042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G